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Abstract
Within the nervous system, heparan sulfate (HS) of the cell surface and extracellular matrix
influences developmental, physiologic and pathologic processes. HS is a functionally diverse
polysaccharide that employs motifs of sulfate groups to selectively bind and modulate various
effector proteins. Specific HS activities are modulated by 3-O-sulfated glucosamine residues, which
are generated by a family of seven 3-O-sulfotransferases (3-OSTs). Most isoforms we herein
designate as gD-type 3-OSTs because they generate HSgD+, 3-O-sulfated motifs that bind the gD
envelope protein of herpes simplex virus 1 (HSV-1) and thereby mediate viral cellular entry. Certain
gD-type isoforms are anticipated to modulate neurobiologic events, because a Drosophila gD-type
3-OST is essential for a conserved neurogenic signaling pathway regulated by Notch. Information
about 3-OST isoforms expressed in the nervous system of mammals is incomplete. Here, we identify
the 3-OST isoforms having properties compatible with their participation in neurobiologic events.
We show that 3-OST-2 and 3-OST-4 are principal isoforms of brain. We find these are gD-type
enzymes, as they produce products similar to a prototypical gD-type isoform, and they can modify
HS to generate receptors for HSV-1 entry into cells. Therefore, 3-OST-2 and 3-OST-4 catalyze
modifications similar or identical to those made by the Drosophila gD-type 3-OST that has a role in
regulating Notch signaling. We also find that 3-OST-2 and 3-OST-4 are the predominant isoforms
expressed in neurons of the trigeminal ganglion, and 3-OST-2/4-type 3-O-sulfated residues occur in
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this ganglion and in select brain regions. Thus, 3-OST-2 and 3-OST-4 are the major neural gD-type
3-OSTs, and so are prime candidates for participating in HS-dependent neurobiologic events.
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1. Introduction
Heparan sulfate (HS)4 is expressed by the majority of mammalian cell-types as side chains on
cell surface and extracellular matrix proteoglycans that regulate numerous biological pathways
(Gallagher, 2001;Iozzo et al., 2001;Rosenberg et al., 1997;Sasisekharan et al., 2002). Within
the nervous system, HS influences such developmental processes as neurogenesis and
differentiation, axon branching and guidance, and synaptogenesis (Bulow et al.,
2002;Chipperfield et al., 2002;Ford-Perriss et al., 2002;Grobe et al., 2005;Inatani et al.,
2003;Irie et al., 2002;Kamimura et al., 2004;Yamaguchi, 2001). In the adult, HS continues to
modulate important neurologic activities such as learning and eating behavior (Kaksonen et
al., 2002;Reizes et al., 2001). HS also participates in pathological events, including
Alzheimer’s disease (Goedert et al., 1996;Hasegawa et al., 1997;Paudel et al., 1999).
The functional diversity of HS stems from its structural complexity, which results from its
intricate pathway of biosynthesis. HS is produced as a proteoglycan (HSPG) consisting of a
protein core with attached HS chains. The HS moieties are linear copolymers composed of up
to 100 disaccharide units of N-acetylglucosamine (GlcNAc) α1→4 glucuronic/iduronic acid
(GlcA/IdoA) β/α1→4. Structural heterogeneity arises from the remodeling of the copolymer
backbone by a relatively ordered series of reactions involving an epimerase and four families
of sulfotransferases (reviewed by Esko et al., 2001;Iozzo, 2001). The sulfotransferases
differentially place N- and O- sulfate groups within HS. The arrangement of these critical
groups along the HS chain creates distinct binding motifs that can activate an array of important
effector proteins.
3-O-Sulfation of glucosamine residues is a key regulator of discrete HS activities. The activities
of several effectors are influenced by selective binding to 3-O-sulfated HS motifs. The best
characterized interaction involves the antithrombin-binding site, which accelerates
antithrombin neutralization of proteases of the blood coagulation cascade (Shworak et al.,
1995). Additionally, 3-O-sulfated HS has been found to bind to fibroblast growth factor 7, to
a receptor for fibroblast growth factors, and to the envelope glycoprotein D (gD) of herpes
simplex virus type 1 (HSV-1) (Liu et al., 1996;McKeehan et al., 1999;Shukla et al., 1999;Ye
et al., 2001). Biosynthesis of discrete 3-O-sulfated motifs is controlled by distinct forms of HS
3-O-sulfotransferase (3-OST). Indeed, 3-OSTs comprise the largest multigene family of HS
biosynthetic enzymes, with a total of seven different 3-OST isoforms having been identified
(Daniels et al., 2001;Shworak et al., 1999;Xia et al., 2002).
All 3-OSTs exhibit a conserved C-terminal sulfotransferase domain, which determines
enzymatic sequence specificity such that isoforms preferentially generate a subset of 3-O-
sulfated motifs (Shworak et al., 1999;Yabe et al., 2001). 3-OST-1 principally creates HS with
4The abbreviations used are: HS, heparan sulfate; 3-OST, HS 3-O-sulfotransferase; HSgD+, HS with gD-binding sites; HSV-1, herpes
simplex virus 1; HSPG, HS proteoglycan; GlcNAc, N-acetylglucosamine; GlcA, D-glucuronic acid; IdoA, L-iduronic acid; gD,
glycoprotein D; HSAT+, HS with antithrombin-binding motifs; LCM, laser capture microdissection; Hep I-III, heparinase I, II, and III;
LC/MS, liquid chromatography/mass spectrometry; ΔUA2S, 4,5-unsaturated uronic acid 2-O-sulfate; IdoA2S, L-iduronic acid 2-O-
sulfate; GlcNS3S, glucosamine N-sulfate 3-O-sulfate; GlcNS3S6S, glucosamine N-sulfate 3-O-sulfate 6-O-sulfate; GlcN(S/H)3S±6S,
glucosamine N-sulfate or free amino 3-O-sulfate with or without 6-O-sulfate; PBS, phosphate buffered saline; DBA, dibutylamine.
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antithrombin-binding sites (HSAT+); 3-OST-3A, 3-OST-3B, and 3-OST-6 primarily generate
HS with gD-binding sites (HSgD+); and 3-OST-5 efficiently produces both HSAT+ and
HSgD+ (Liu et al., 1999b;Shukla et al., 1999;Xia et al., 2002;Xu et al., 2005;Yabe et al.,
2001). These enzymes, with their distinct substrate specificities, are ideally suited to regulate
biologic activities of HS as: 1) 3-O-sulfates are the rarest HS modifications, 2) 3-OSTs act very
late in HS biosynthesis, 3) 3-OST activity can be rate-limiting to control the cellular level of
3-O-sulfated motifs, and 4) the large multiplicity of genes allows tremendous regulatory
flexibility with individual isoforms exhibiting cell-type, tissue-specific, and temporal
regulation (Borjigin et al., 2003;Colliec-Jouault et al., 1994;Kamimura et al., 2004;Kuberan et
al., 2004;Shworak et al., 1994a;Shworak et al., 1996;Shworak et al., 1997;Shworak, 2001).
3-OSTs are expected to modulate neurobiologic processes, as a Drosophila 3-OST isoform
regulates Notch signaling (Kamimura et al., 2004), which is an essential metazoan pathway
known to control mammalian central nervous system development and function (Artavanis-
Tsakonas et al., 1999;Grandbarbe et al., 2003). Indeed, several mammalian 3-OST isoforms
are expressed in the brain (Mochizuki et al., 2003;Shworak et al., 1999); however, it is unknown
if any of these isoforms exhibit neuronal expression. The identification of the major neuronal
3-OST isoforms would enable investigations into whether these critical regulators of HS motifs
are involved in developmental, physiological and pathological aspects of neurobiology.
HSV-1 is a major neuropathogen that potentially can exploit endogenous 3-O-sulfated HS for
entry into neurons or for other aspects of the infection process (Shukla et al., 2001). Viral entry
is triggered by interactions between glycoprotein gD and any one of several cell surface
components (Spear et al., 2000), including HSgD+ (Liu et al., 2002;Shukla et al., 1999;Xu et
al., 2005;Yoon et al., 2003). Evidence has been presented that another HSV-1 receptor,
nectin-1, can mediate the entry of the virus into cultured cells of neuronal origin (Manoj et al.,
2004;Richart et al., 2003) but this evidence does not rule out a role for 3-O-sulfated HS in
HSV-1 infection of neurons in situ. Typically, an initial HSV-1 infection can spread from
mucosal or skin epithelial cells to the neurons of sensory ganglia such as the trigeminal ganglia.
These neurons can then harbor latent HSV-1, which upon reactivation causes recurrent herpes
(cold sores, for example). HSV-1 infection can also spread into the central nervous system,
where it is the most common cause of sporadic, fatal encephalitis in the United States (reviewed
by Schmutzhard, 2001).
Here, we show that 3-OST-2 and 3-OST-4 are major brain/neuronal 3-OST isoforms with
properties that make them prime candidates for participating in HS-dependent neurobiologic
events.
2. Results
2.1. Identification of major brain 3-OST isoforms
To identify 3-OST isoforms having properties compatible with their participation in
neurobiologic events, we first determined the predominant 3-OST isoforms in brain. We
measured the levels of transcripts from all seven 3-OST genes by real time PCR of total RNA
extracted from mouse brain. Each isoform is expressed to some degree in the brain (Fig. 1).
However, 3-OST-1, 3-OST-2, and 3-OST-4 predominate with transcript levels being at least
10-fold higher than those of the remaining isoforms. We have previously determined that 3-
OST-1 is principally expressed in endothelial cells (Shworak et al., 1997); whereas, 3-OST-2
and 3-OST-4 are primarily and exclusively expressed in brain, respectively (Shworak et al.,
1999). Together, these data raise the possibility that 3-OST-2 and 3-OST-4 may be the major
isoforms expressed in neurons.
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2.2. Neurons of the trigeminal ganglion express 3-OST-2 and 3-OST-4
We initially tested for neuronal expression by performing in situ hybridizations on mouse brain
sections. 3-OST-2 and 3-OST-4 mRNAs exhibited distinct patterns of expression in subsets
of neurons in multiple brain regions. These neuronal expression patterns were extremely
complex and so shall be elaborated upon in a separate publication5. Here, we describe their
expression in the mouse trigeminal ganglion, which exhibits abundant sensory neurons with
well defined projections.
For both 3-OST-2 and 3-OST-4, significant hybridization signals were detected primarily in
regions containing neuronal cell bodies, with individual neurons differing in the level of
expression (Fig. 2). Only a subset of neurons expressed 3-OST-2, whereas 3-OST-4 expression
was detected in the majority of neurons. Moreover, the 3-OST-4 hybridization signal
overlapped some satellite cells that were adjacent to neurons with high expression. It is unclear,
however, whether this lower signal truly originates from the satellite cells or from underlying
neuronal cytoplasm within the section plane. Alternatively, this signal may simply reflect
scattered radiation emanating from the highly expressive neurons. Sensitivity limitations
preclude us from ruling out a low expression level of either 3-OST isoform in non-neuronal
cell types. These data demonstrate that within the trigeminal ganglion, 3-OST-2 and 3-OST-4
are predominantly, if not exclusively, expressed in neurons.
2.3. Identification of major 3-OST isoforms in neurons of trigeminal ganglia
The abundance of 3-OST-2 and 3-OST-4 mRNA in trigeminal ganglion neurons was evaluated
by real-time RT-PCR of neuron- or axon/Schwann cell-enriched samples obtained by laser
capture microscopy (LCM) (Fig. 3a). Neuronal cell body samples exhibited strongest
expression for 3-OST-2 and 3-OST-4 (Fig. 3b), with the ganglionic 3-OST-4 mRNA level
being 20% of that for 3-OST-2. Of the remaining isoforms, 3-OST-1, 3-OST-3B and 3-OST-6
transcripts were detectable but at levels lower than that of 3-OST-4. It remains unclear whether
these minor isoforms are expressed in neurons or contaminating satellite cells. In contrast to
the neuron-enriched samples, the expression of all 3-OST isoforms was undetectable in the
axonal/Schwann cell samples. Together with the above anatomical evidence, this quantitative
transcript analysis demonstrates that 3-OST-2 and 3-OST-4 are the major 3-OST isoforms
expressed in neurons of the trigeminal ganglion.
2.4. Isolation of the 3-OST-4 gene and cDNA
Before determining if products of 3-OST-2 and 3-OST-4 exist in neural tissues, we first needed
to characterize the sulfation specificities of these enzymes. These analyses required functional
cDNAs; however, only a partial length 3-OST-4 cDNA existed (Shworak et al., 1999). This
limitation was circumvented by isolating the 3-OST-4 gene and appending a gene fragment to
the available partial-length 3-OST-4 cDNA; thereby supplying the missing sequence. This
technique is described and justified under the “Experimental procedures.”
The resultant full-length 3-OST-4 cDNA encoded a 49,825 Da protein with a type-II
transmembrane topology (Fig. 4). The N-terminal region exhibits features common to most
other 3-OST enzymes, including a short cytoplasmic tail, a hydrophobic membrane spanning
segment, and a SPLAG domain (enriched in Ser, Pro, Leu, Ala, Gly) (Shworak et al., 1999).
Similar to 3-OST-3B, the 3-OST-4 cytoplasmic tail contains a polyproline stretch, which is
thought to be a protein-protein interaction motif (Shworak et al., 1999). The C-terminal region
encompasses a sulfotransferase domain that exhibits the greatest homology to 3-OST-2, 3-
5Lawrence et al, in preparation.
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OST-3A, and 3-OST-3B isoforms (~76 % identity). This high similarity in the sulfotransferase
domain, suggests these enzymes may generate similar 3-O-sulfated structures.
2.5. Identification of 3-OST-2/4-type products in HS
The specificities of 3-OST-2 and 3-OST-4 were assessed by an established approach used to
characterize the sulfation sites of 3-OST enzymes (Kuberan et al., 2002;Lawrence et al.,
2004). We expressed each isoform in a cell line (CHO[Eco]) that normally does not express
3-OST enzymes (HajMohammadi et al., 2003). Retroviral expression constructs were
employed so as to transduce >90% of cells (Chatterton et al., 1999;HajMohammadi et al.,
2003). Cellular HS was degraded with heparinase I, II, and III (Hep I-III) under conditions that
yield 3-O-sulfated disaccharides as well as digestion-resistant 3-O-sulfated tetrasaccharides
(Yamada et al., 1993). The resulting digestion products were resolved by liquid
chromatography/mass spectrometry (LC/MS). HS from non-transduced CHO[Eco] cells
yielded only disaccharides containing N-, 2-O-, and/or 6-O-sulfates (Fig. 5). In addition to
these residues, HS isolated from 3-OST transduced cells contained four 3-O-sulfated products
(Fig. 5). Theses 3-OST-2/4-type digestion products were the disaccharides
ΔUA2S→GlcNS3S, ΔUA2S→GlcNS3S6S (3-O-sulfate in bold), and two Hep I-III resistant
tetrasaccharides (Tetra-A and Tetra-B). Based on their molecular weights, the tetrasaccharides
lack acetyl groups and contain 4 sulfate groups (Tetra-A, MW ~993) or 5 sulfate groups (Tetra-
B, MW ~1073). We have previously found that 3-OST-3A produces identical disaccharides
and two tetrasaccharides of identical molecular weight to Tetra-A and Tetra-B (Lawrence et
al., 2004), indicating that all three 3-OST enzymes exhibit, at the least, similar motif
specificities6.
2.6. Neural tissues expressing 3-OST-2 and 3-OST-4 exhibit 3-OST-2/4-type products
We examined three neural tissues for the specific HS products of 3-OST-2 and 3-OST-4. Tissue
HS was digested with Hep I-III and liberated residues were identified by LC/MS. To provide
the most definitive identification of the digestion products, we present spectra data that reveal
the mass of relevant molecular ions. The 3-OST-2/4-type products are represented by a total
of seven distinct molecular ions; however for simplicity, we present data for two diagnostic
molecular ions – the [M-2H+DBA]-1 form of the disaccharide ΔUA2S→GlcNS3S6S and the
[M-2H]-2 form of Tetra-B. Fig. 6 shows that 3-OST-2/4-type products were detectable in HS
from the trigeminal ganglion and the brain stem but not the cerebellum7. In addition to the
trigeminal ganglion, our in situ hybridizations revealed that 3-OST-2 and 3-OST-4 are also
expressed in select neurons of the brain stem but not of the cerebellum5. Thus, 3-OST-2/4-type
products were selectively detected in the tissues that express 3-OST-2 and 3-OST-4. We cannot
rule out that some of these products are derived from synaptic projections of neurons from
other regions; for example, trigeminal synaptic connections occur in the brain stem but not the
cerebellum. Nevertheless, 3-OST-2 and 3-OST-4 are the major brain/neuronal 3-OST isoforms
capable of making 3-OST-2/4-type products. Thus, the majority of such products detected in
6We have ruled out that 3-OST-2 and 3-OST4 function like 3-OST-5, which has a partially overlapping specificity (Lawrence et al.,
2004). HS modified by any of these enzymes yields 3-OST-3A-like products. However, 3-OST-5 modification also leads to high levels
of 3-OST-1-type digestion products (ΔUA→GlcNS3S and ΔUA→GlcNS3S6S) (Xia et al., 2002). These signature disaccharides of
HSAT+ are always found in near equimolar levels. Our chromatography system readily detects ΔUA→GlcNS3S6S (retention time of
~55 min), which exhibits baseline separation from ΔUA→GlcNS6S (retention time of ~57 min) (Lawrence et al., 2004). All Fig. 5
samples lack a peak in the ΔUA→GlcNS3S6S position. Moreover, water and DBA combine with ΔUA→GlcNS3S6S to form adducts
with unique molecular masses (Lawrence et al., 2004); these distinctive molecular ions were not detected in our LC/MS analyses of 3-
OST-2/4 digestion products (not shown). Thus, we conclude that 3-OST-2 and 3-OST-4 exhibit a distinct specificity from 3-OST-5,
which produces substantial levels of 3-OST-1-type digestion products.
7Despite our previous finding that brain HSAT+ is predominantly derived from 3-OST-1 (HajMohammadi et al., 2003), our LC/MS
analysis did not detect ΔUA→GlcNS3S6S in neural HS samples. Our inability to detect this major 3-OST-1 digestion product is consistent
with the rarity of 3-OST-1 derived disaccharides (<0.5% of sulfated disaccharides from cell lines expressing “high” levels of HSAT+)
(Colliec-Jouault et al., 1994;Shworak et al., 1994a). We conclude that in neural tissue, 3-OST-2/4-type 3-O-sulfated HS structures are
far more abundant than 3-OST-1 modified residues.
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select neural tissues likely result from the selective expression of 3-OST-2 and 3-OST-4 in
local and/or distant neurons.
2.7. 3-OST-2 and 3-OST-4 mediate HSV-1 entry
Their similar motif specificities suggest that 3-OST-2, 3-OST-3A and 3-OST-4 may convey
comparable cell biologic properties. Thus, we tested whether 3-OST-2 and 3-OST-4 function
similarly to 3-OST-3A or 3-OST-3B, which we have shown generate HSgD+ that confers
susceptibility to infection by HSV-1 (Shukla et al., 1999;Yabe et al., 2001). CHO cells, which
are normally resistant to HSV-1, were transfected with plasmids expressing various 3-OSTs
and then exposed to HSV-1(KOS)tk12 – a recombinant HSV-1 strain that, upon entry into
cells, expresses β-galactosidase. We found that expression of 3-OST-2 or 3-OST-4 was
associated with enhanced susceptibility of the transfected cells to HSV-1 entry (Fig. 7), similar
to that observed with the previously characterized 3-OST-3A and 3-OST-3B (Shukla et al.,
1999;Yabe et al., 2001). These results conform with our prior finding that the conveyance of
HSV-1 entry is dependent on the enzymatic specificity of the 3-OST isoform; as shown
previously, the distinct 3-O-sulfated HS motifs generated by 3-OST-1 are unable to mediate
HSV-1 entry (Shukla et al., 1999;Yabe et al., 2001).
3. Discussion
HS plays critical developmental and pathophysiological roles in the nervous system
(Chipperfield et al., 2002;Ford-Perriss et al., 2002;Goedert et al., 1996;Hasegawa et al.,
1997;Inatani et al., 2003;Irie et al., 2002;Kaksonen et al., 2002;Paudel et al., 1999;Reizes et
al., 2001;Yamaguchi, 2001). For example, HS of the extracellular matrix controls axonal
guidance by modulating matrix signaling through receptors such as integrins (Bulow et al.,
2002;Lee et al., 2004). However, the involvement of glucosamine 3-O-sulfation, which can
regulate discrete HS activities, is presently unknown. To enable investigations into potential
neural functions of this important HS modification, we sought to identify and characterize
neuronal 3-OST isoforms. Our study reveals that 3-OST-2 and 3-OST-4 are major brain/
neuronal 3-OST isoforms with properties that make them prime candidates for participating in
HS-dependent neurobiologic events.
We first identified the major 3-OST isoforms expressed in the brain. Real-time PCR analyses
demonstrated that in the mouse brain 3-OST-1, 3-OST-2 and 3-OST-4 are by far the most
abundantly expressed isoforms. 3-OST-1 mRNA occurs in all organs (HajMohammadi et al.,
2003;Shworak et al., 1999); whereas 3-OST-2 and 3-OST-4 are preferentially expressed in the
central nervous system (Shworak et al., 1999). Thus we focused on these latter two major brain
isoforms.
In situ hybridizations of brain and trigeminal ganglion demonstrated that 3-OST-2 and 3-OST-4
are both expressed predominantly, if not exclusively, in subpopulations of neurons. Our results
do not rule out neuronal expression of other 3-OST isoforms; however, our in situ analyses
combined with the quantitation of brain and trigeminal ganglion transcripts, indicate that 3-
OST-2 and 3-OST-4 are the major 3-OST isoforms of neurons.
We addressed whether neuronal expression of 3-OST-2 and 3-OST-4 might affect the structure
of neural HS. This process was enabled by our isolation of the 3-OST-4 gene, which provided
the first full length 3-OST-4 cDNA for identification of its enzymatic reaction products. LC/
MS analysis of HS from transduced cells demonstrated that 3-OST-2 and 3-OST-4 catalyze
similar, if not identical, modifications when resolved at the disaccharide and tetrasaccharide
levels. Detectable levels of these 3-OST-2/4-type digestion products were only present in HS
from neural tissues that express 3-OST-2 and 3-OST-4 (the trigeminal ganglion and brain stem,
but not the cerebellum). On one hand, these data suggest that region specific expression of
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these isoforms may lead to region specific accumulation of 3-OST-2/4-type products. On the
other hand, HSPGs generated by neurons can undergo axonal transport (Dow et al.,
1994;Ripellino et al., 1988). Thus, 3-OST-2/4-type products generated in neuronal cell bodies
may also be transported to their distant nerve endings. 3-OST-2 and 3-OST-4 expressing
neurons may well have 3-OST-2/4-type products on axons and within synapses, as these
structures contain HSPGs (Van Vactor et al., 2006). Moreover, modification of HSPGs occurs
independent of the core protein (Shworak et al., 1994a;Zako et al., 2003); thus, 3-OST
expressing neurons should have 3-O-sulfated HS on their entire repertoire of core proteins,
including synaptic HSPGs. Unfortunately, we presently cannot test this important hypothesis,
which would require an as yet unavailable in situ probe that selectively binds to 3-OST-2/4-
modified HS. Thus, it remains to be determined whether the detected 3-OST-2/4-type products
are derived from local and/or distant neurons8. Regardless, it is most likely that the 3-O-sulfated
HS products detected in select neural tissues are predominantly derived from 3-OST-2 and 3-
OST-4, which are by far the major neuronal 3-OST isoforms that specifically generate such
products.
The 3-OST-2/4-type products are also similar, if not identical, to disaccharide and
tetrasaccharide products we have previously identified for 3-OST-3A (Lawrence et al., 2004),
suggesting that all three isoforms may regulate similar cellular processes. Indeed, we found
that 3-OST-2 and 3-OST-4 mediate cellular entry of HSV-1 as previously shown for 3-
OST-3A and 3-OST-3B, which generate HSgD+ for the HSV-1 receptor-binding glycoprotein,
gD (Shukla et al., 1999). Thus, the comparable biochemical and viral entry data suggest that
3-OST-2 and 3-OST-4, like 3-OST-3A and 3-OST-3B, act by generating specific 3-O-sulfated
sequences in HS that bind gD to trigger cellular entry of HSV-19.
With the above characterizations, it is now apparent that the large 3-OST multigene family
shows two major sequence specificities (Fig. 8). 3-OST-2, 3-OST-3A, 3-OST-3B, 3-OST-4,
and 3-OST-6 (Shukla et al., 1999;Xu et al., 2005, and data herein) preferentially generate
HSgD+ and so may be classified as gD-type enzymes. These isoforms show highly homologous
sulfotransferase domains, consistent with this domain defining enzymatic sequence specificity
(Yabe et al., 2001). The most structurally distinct enzyme, 3-OST-1, preferentially generates
HSAT+ (Shworak et al., 1997) and is unable to convey susceptibility to HSV-1 cellular entry
(Shukla et al., 1999;Yabe et al., 2001), so may be considered as an AT-type enzyme. 3-OST-5
exhibits both specificities (Xia et al., 2002), and must be considered a member of both classes.
Thus, the majority of 3-OST isoforms can efficiently synthesize HSgD+.
The full structure of the gD-binding motif has yet to be elucidated; however, a partial sequence
has been proposed which encompasses the 3-OST-2/4-type product Tetra-B (Liu et al.,
2002). Due to differing methods of analysis, it is not yet known whether all gD-type isoforms
generate Tetra-B. Based on the known enzyme specificities (Kuberan et al., 2004;Liu et al.,
1999a;Wu et al., 2004;Xia et al., 2002;Xu et al., 2005, and data herein), the minimum common
structure produced by all gD-type isoforms is →IdoA2S→GlcN(S/H)3S±6S→; thus, this
disaccharide motif is likely a key component of the gD-binding site. It remains to be determined
whether individual gD-type isoforms generate structurally identical or distinct gD-binding
sites.
Recent studies in Drosophila melanogaster suggest a critical role for the mammalian gD-type
isoforms (Kamimura et al., 2004). Drosophila encodes only two 3-OST genes – HS3ST-A and
8We have detected 3-OST-2/4-type products in trigeminal sensory fields, however, multiple cell types exist in these tissues so the cell
types and 3-OST isoforms responsible for these products is entirely unclear.
9Indeed, evidence that 3-OST-2 and 3-OST-4 generate gD binding sites was recently published (Tiwari et al., 2005) while this manuscript
was in preparation.
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HS3ST-B. The HS3ST-B enzyme is structurally most similar to the mammalian gD-type
enzymes and its ectopic expression renders CHO cells susceptible to HSV-1 entry to the same
extent as mammalian gD-type 3-OSTs (Kamimura et al., 2004). Gene silencing of HS3ST-B
produces neurogenic phenotypes through cell autonomous inhibition of Notch signaling.
HS3ST-B was found to act downstream of Notch transcription to enable accumulation of this
receptor on the cell surface (Kamimura et al., 2004). Given the above structural and functional
homologies, the mammalian gD-type isoforms may well serve to regulate cell surface levels
of Notch receptors. Indeed among metazoans, Notch signaling components are extremely
conserved (Artavanis-Tsakonas et al., 1999). During mammalian development, Notch
receptors regulate cell fate by inhibiting neurogenesis and promoting gliogenesis (Grandbarbe
et al., 2003). Notch signaling is additionally required for maintenance of neural stem cells
(Artavanis-Tsakonas et al., 1999), which allow for neuron generation in sub-regions of the
adult brain (Alvarez-Buylla et al., 2004). Mature neurons also express Notch isoforms,
suggesting additional roles for these receptors in the adult nervous system (Irvin et al.,
2001;Sestan et al., 1999). Given that 3-OST-2 and 3-OST-4 are major neuronal gD-type
enzymes, they might be required for key Notch regulated events that determine cell fate in the
developing and adult nervous system. A detailed analysis of this question is underway.
Our studies also suggest that of all gD-type isoforms, 3-OST-2 and 3-OST-4 are preferential
candidates for involvement in HSV-1 infection of the nervous system. 3-OST-2 and 3-OST-4
are by far the most abundant gD-type isoforms in the central nervous system and so are likely
the major source of neural 3-OST-2/4-type products. In particular, these isoforms are expressed
in neurons of the trigeminal ganglion and perhaps other sensory ganglia, sites where HSV-1
establishes latent infections. However, it is presently unknown whether 3-O-sulfated HS occurs
on nerve termini and is involved in HSV-1 infection of neurons. Moreover, there are additional
cell surface receptors (herpesvirus entry mediator, and nectin-1) that can mediate HSV-1
infection of cultured cells (Cocchi et al., 1998;Geraghty et al., 1998;Montgomery et al.,
1996;Warner et al., 1998). Of these, nectin-1 is also known to be expressed in neurons of the
trigeminal ganglion (Haarr et al., 2001) and has been implicated in HSV-1 entry into cultured
cells of neuronal origin (Manoj et al., 2004;Richart et al., 2003). Thus, more extensive studies
will be required to evaluate whether in vivo HSV-1 infection involves 3-O-sulfated HS
generated by neuronal gD-type 3-OSTs and/or the other candidate HSV-1 entry receptors.
Our identification of 3-OST-2 and 3-OST-4 as major neural gD-type 3-OSTs is a critical first
step towards evaluating the involvement of neuronal 3-O-sulfated HS in the development and
functioning of the central nervous system and in neuropathologies such as in vivo HSV-1
infection.
4. Experimental procedures
4.1. Cell lines and viruses
CHO-K1 (Esko et al., 1985) cells were cultured in Ham’s F12 medium containing 10% fetal
calf serum, 100 units/ml penicillin, 100 μg/ml streptomycin, and 2 mM glutamine. CHO[Eco]
is a CHO-K1 derivative expressing the ecotropic retrovirus receptor (Gu et al., 2000). Phoenix
cells (ATCC SD 3444) were grown in DMEM containing 10% fetal calf serum, 50 units/ml
penicillin, 50 μg/ml streptomycin, and 2 mM glutamine. HSV-1(KOS)tk12 has been described
elsewhere (Warner et al., 1998). The retroviral vector MVT-37 was prepared from the
MSCVpac retroviral vector (Hawley et al., 1994) as described (Lawrence et al., 2004). The
complete coding sequences for human clones of 3-OST-2 and 3-OST-4 were subcloned into
appropriate restriction sites of MVT-37. The Phoenix packaging line was transfected with these
3-OST constructs by calcium phosphate, as previously described (Gu et al., 2000) and retroviral
supernatants were snap frozen. CHO[Eco] cells were transduced as previously described (Gu
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et al., 2000) then selected with 7.5 μg/ml puromycin (Sigma-Aldrich, St. Louis, Missouri,
USA).
4.2. Quantitation of 3-OST transcript levels by real time RT-PCR
All animal experiments were performed following review and approval by Institutional Animal
Care and Use Committees of Dartmouth and MIT, respectively. Brains were harvested from
4-5 month old male and female mice (C57BL/6 x 129S4/SvJae F1 hybrids) and RNA was
harvested by the TRI Reagent (Sigma-Aldrich, St. Louis, Missouri, USA) protocol. Real time
PCR was performed as previously described (Girardin et al., 2005). In brief, first strand
synthesis of cDNA was performed with a mixture of eight primers specific to the 3’ untranslated
regions of the target genes (β-actin and each 3-OST isoform). SYBR Green based real time
PCR was then performed on cDNA derived from 10 ng of total RNA. Pairs of β-actin or 3-
OST isoform specific primers were targeted to unique sequences within the 3’ untranslated
region using the program Primer Express (Applied Biosystems) and are described by
HajMohammadi et al.10. All PCR products were subjected to melting curve analysis to confirm
amplification of a single anticipated target. All PCR products were cloned, sequence verified,
and used to make quantitation standards that ranged from 1 million down to 200 copies per
reaction. Results were expressed as 3-OST transcripts per 300,000 β-actin transcripts, which
was the average β-actin level per PCR reaction.
4.3. In Situ Hybridization
Adult male mice (C57BL/6J), about three months old, were anesthetized by inhalation of
isofluorane, then exsanguinated by incision of the inferior vena cava and perfusion of 6 ml of
phosphate buffered saline (PBS) through the left ventricle. Fixative (4% formaldehyde freshly
prepared in PBS) was next perfused at 6 ml/min for 5 min, then at 2.75 ml/min for 30 min.
Tissues were removed, immersed in the fixative for up to 12 h at 5 ºC, subjected to dehydration,
and embedded in paraffin. Sections of 5 μm thickness on microscope slides were stored at 5
ºC.
Tissue sections were deparaffinized in xylene, rehydrated using a graded ethanol series (100%
to 30%), rinsed in 150 mM NaCl and PBS, each for 5 min, and post-fixed in 4% formaldehyde
in PBS for 30 min. Slides were treated with 20 μg/ml proteinase K (Roche Molecular
Biochemicals, Indianapolis, Indiana, USA) in 50 mM Tris-HCl, pH 7.2, containing 5 mM
EDTA at room temperature for 7.5 min and fixed in 4% formaldehyde in PBS. Acetylation
was carried out for 10 min with 0.25% acetic anhydride in 100 mM triethanolamine, pH 8.0,
and slides were rinsed sequentially in PBS and 150 mM NaCl, dehydrated through a graded
ethanol series and allowed to dry at least 2 h prior to hybridization.
Probes were obtained by PCR from a murine brain cDNA library (CLONTECH Laboratories
Inc., Palo Alto, California, USA). A 923 bp 3-OST-2 probe (GenBank accession number
AY533705) was generated using PCR primers dTCGCTCTCCTGCACTTACCTGT and
dGGATCAATCTGTACATGAGTTCTCCC which span nucleotides 78-1015 of the
corresponding human 3-OST-2 coding sequence (GenBank accession number AF105374). A
235 bp 3-OST-4 probe (GenBank EST accession number BB311177) was isolated with the
PCR primers dTCTCCAGACATCCTTTTCAAG and dAGGTTGCATTAAGCTTTATAAC.
The cDNA fragments were inserted into pBluescript KS+ and sense or antisense riboprobes
were synthesized with either T7 or T3 RNA polymerases from EcoR I or Xho I linearized
plasmids, respectively, using a commercial kit (Promega, Madison WI) according to the
manufacturer’s instructions. Riboprobes were resuspended in 20 μl of 1 M DTT and 180 μl of
hybridization buffer containing 20 mM Tris-HCl, pH 7.4, 5 mM EDTA, 10 mM Na2HPO4,
10S. HajMohammadi, J. M. Rhodes, M. McNeely, P. G. Spear and N. W. Shworak, in preparation.
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50% deionized formamide, 300 mM NaCl, 1 X Denhardt’s solution, 10% dextran sulfate and
0.5 mg/ml of yeast total RNA.
Hybridization was carried out as previously described (Toselli et al., 1992). Briefly, tissue
sections were overlaid with 30 μl of 35S-labeled probes (25,000 cpm/μl in hybridization buffer)
and 22 x 22 mm cover slips. Hybridization was carried out at 52 °C for 16 h in a humidified
chamber. Slides were washed in 5 X SSC with 10 mM DTT at 50 °C for 30 min and
subsequently in 2 X SSC, 50% formamide and 10 mM DTT at 65 °C for 20 min. Slides were
rinsed twice at 37 °C for 10 min in STE (10 mM Tris-HCl, pH 7.5, 400 mM NaCl and 5 mM
EDTA) then treated with RNase A (20 μg/ml) in STE at 37 °C for 45 min. Sections were washed
with STE for 5 min, with 2 X SSC for 15 min, and with 0.1 X SSC for 15 min, each at 37 °C.
Sections were dehydrated in an ethanol series (30-95%) in 0.3 M ammonium acetate and finally
in 100% ethanol. Sections were coated in Kodak NTB-2 nuclear track emulsion and placed in
a desiccation chamber for 8-10 weeks at 4°C. Slides were developed in Kodak D-19 developer,
stained with hematoxylin and eosin and photographed using a Leitz Dialux 20 light microscope
(Wetzlar, Germany).
4.4. LCM
Isofluorane-anesthetized male C57BL/6J mice were exsanguinated, as above but without
perfusion or fixation, and trigeminal ganglia were removed and frozen in OCT and stored at
-80 ºC. Longitudinal sections (8 μm thickness) were mounted on glass slides. An Arcturus
PixCell II laser-capture microdissection microscope was used to recover specific fields of either
ganglion cell bodies or axons and their associated Schwann cells. The respective cell types
were recovered from serial sections separated by 24 μm within the tissue. As per the
manufacturer’s instructions, RNA was extracted with a PicoPure RNA isolation kit (Arcturus
Engineering Inc., Mountain View, California, USA) and subjected to two rounds of
amplification with a RiboAmp RNA amplification kit (Arcturus Engineering Inc.). Amplified
RNA samples were quantitated and monitored for quality with an Agilent 2100 Bioanalyzer
using RNA 6000 Nano Chips (Agilent Technologies, Palo Alto, California, USA). Real-time
PCR was conducted as above, except that during the first strand synthesis, the cRNA was
primed with random hexamers. Results were standardized to levels of β-actin, which were
comparable between neuronal and axonal groups.
4.5. Isolation and Characterization of the HS3ST4 coding region
We had initially isolated a partial length human 3-OST-4 cDNA (GenBank accession number
AF105378) (Shworak et al., 1999). We attempted recovering the missing coding sequences
from brain mRNA samples by three separate approaches (screening a total brain cDNA library
(Shworak et al., 1999), screening a primer extension cDNA library generated with a 3-OST-4
specific primer, and conducting 5’-RACE). These mRNA based techniques were unsuccessful;
consequently, genomic sequences were isolated. The primers 5’-
dGCGCGCTGCTGGAGGCGAT and 5’-dGTCTTGGGCATCACATTTCTGTA were used
to amplify the cDNA nucleotides 14-134 (of AF105378). A human BAC library (Genome
Systems Inc., St. Louis, Missouri, USA) was screened with the resulting probe and three
independent genomic clones were detected. Separate EcoR I sub-libraries in pZerO-1 (Gibco
Invitrogen, Grand Island, New York, USA) were generated from each, and re-screening
identified clones containing an identical 4045 bp insert (GenBank accession number
AY476736) containing the 5’ end of the HS3ST4 gene. Sequencing, as previously described
(Shworak et al., 1997;Shworak et al., 1999), revealed a single exon containing 734 bp of coding
sequence that initiated with a strong Kozak sequence (Kozak, 1996). The 3’ end of this exon
had 116 bp of overlap to the partial cDNA. Given that the cDNA overlapped with the first
coding exon, a composite 3-OST-4 cDNA sequence was compiled with genomic nucleotides
2457 to 3579, which correspond to Fig. 4 composite nucleotides 1 to 1123, and with the partial
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cDNA (AF105378) representing nucleotides 1008 to 3201. The first 900 bp of the composite
cDNA were exceedingly GC rich (70-87 %); thereby accounting for the above difficulty in
directly isolating a full length cDNA. The composite cDNA predicts a 3-OST-4 transcript of
~3.2 kb, which corresponds well to the ~3.4 kb value we previously determined by Northern
blot analysis (Shworak et al., 1999). This composite was confirmed by recently isolated
expressed sequence tag clones. GenBank accession number AL834283 confirmed an additional
257 bp of overlap; whereas, GenBank accession number BI552211 shows overlap up to
nucleotide 1 of the composite sequence.
4.6. Plasmid expression constructs
Expression plasmids containing human 3-OST-2 (pcDNA3-JL2.7) and 3-OST-3A (pcDNA3-
JL3.3) were described previously (Liu et al., 1999a;Shworak et al., 1997;Shworak et al.,
1999). A functional 3-OST-4 cDNA was generated using an EcoO109 I site common to
AF105378 and the genomic sequence. The 5’ untranslated region was removed as it exhibited
a pure GC inverted repeat (Fig. 4) that might limit translation. The genomic coding region,
preceded by a BamH I site (underlined), was isolated by PCR with the primers 5’-
dAAAAGGATCCATGGCCCGGTGGCCCGCACCTCCT and 5’-
dTTTCTGTACCACTCCAACCC. PCR was carried out with Taq Gold polymerase
(PerkinElmer Life and Analytical Sciences Inc., Boston, Massachusetts, USA) by 20 cycles of
95 °C for 30 sec, 58 °C for 45 sec, and 75 °C for 1 min in 10% (v/v) dimethyl sulfoxide. The
PCR product was cloned into PCR-Script Cam (Stratagene Inc., La Jolla, California, USA)
then digested with EcoO109 I and ligated to a 1.7-kb EcoO109 I fragment of the partial cDNA
(Shworak et al., 1999). The resulting complete 3-OST-4 coding region was subcloned into
pcDNA3.1 as a 1.5-kb BamH I fragment.
4.7. Isolation of cell and tissue HS
Confluent transduced CHO[Eco] cells (five 150-mm dishes) were washed with PBS then
subjected to exhaustive proteolysis for 24 hours at 37 ºC in 120 ml digest buffer (0.17 mg/ml
protease (EC 3.4.24.31, Sigma-Aldrich, St. Louis, Missouri, USA) in 40 mM sodium acetate,
320 mM sodium chloride, pH 6.5). The pooled supernatants were diluted 1.5 X with water and
applied to a 0.5 ml DEAE Sepharose (Pharmacia Biotech, Piscataway, New Jersey, USA)
column, washed with 25 bed volumes of 250 mM sodium chloride, 20 mM sodium acetate,
0.02% weight/volume sodium azide, pH 6.0 and eluted with 2.5 ml of 1 M sodium chloride,
20 mM sodium acetate, pH 6.0. Polysaccharide chains were then precipitated with 10 ml 100%
ethanol overnight at 4 ºC and centrifuged at 2500 g for 10 min at 4 ºC. Pellets were washed
with 10 ml ice cold 70% ethanol, re-centrifuged, air dried, dissolved in 0.1 to 0.2 ml sterile
water and stored at 4 ºC until analyzed. Alternatively, tissues harvested from adult (3 month
old) C57BL/6 mice were homogenized in PBS and HS was isolated as just described.
4.8. LC/MS Analysis of Hep I-III Derived HS Residues
HS preparations (about one third of the extracted HS mass in 10 μl) were combined with 82
μl of 24.4 mM ammonium acetate with 2 mM calcium acetate and 1 μl containing 0.33 mU
each of Hep I-III (Seikagaku America Inc., Bethesda, Maryland, USA). Samples were digested
for 16 h at 37 ºC then lyophilized and reconstituted in 7 μl water plus 1 μl of ion pairing reagent
dibutylamine (DBA) and subjected to LC/MS analysis, as previously described (Kuberan et
al., 2002;Lawrence et al., 2004). In addition to the raw ionic weight for each residue, the
combined weight for adduct ions formed with DBA was also analyzed. The extracted ion
current was computed as described in the documentation for the Data Explorer software
provided by Applied Biosystems (Foster City, CA, USA).
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4.9. HSV-1 entry assay
Determination of CHO transfectant susceptibility to HSV-1 entry has been previously
described (Montgomery et al., 1996;Shukla et al., 1999;Yabe et al., 2001). Briefly,
subconfluent CHO-K1 cells in 6-well dishes were transfected with empty control vector or
pcDNA3-based plasmids expressing one of the 3-OSTs (Yoon et al., 2003), using
Lipofectamine (Gibco Invitrogen, Grand Island, New York, USA) according to the
manufacturer's recommendations and 1.5 μg of plasmid DNA per well in 1 ml. At 24 h after
transfection, the cells were replated in 96-well tissue culture dishes at 2-4 x 104 cells per well.
About 16 h later, the cells were washed and exposed to serial dilutions of HSV-1(KOS)tk12
prepared in PBS containing glucose and 1% calf serum (100 μl of virus dilution per well in
triplicate). Input multiplicities of infection ranged from about 102 to 104 PFU of virus per cell.
It should be noted that the effective multiplicity of infection was about 1/1500 of these values,
due to the fact that most input virus does not make contact with cells in small wells loaded
with a large volume relative to the small monolayer surface area. After incubation with virus
at 37 ºC for 6 h, sufficient time to allow for viral entry and expression of viral genes, the cells
were solubilized in 100 μl of PBS containing 0.5% NP-40 and the β-galactosidase substrate,
O-nitro-phenyl β-D-galactopyranoside. Generation of the β-galactosidase product was
monitored at 405 nm in a Victor Wallac spectrophotometer (PerkinElmer Life and Analytical
Sciences Inc., Boston, Massachusetts, USA).
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Fig 1. Expression level of 3-OST isoforms in brain
Real-time RT-PCR of mouse brain total RNA was conducted using isoform specific primers
for both first strand synthesis and PCR amplification. Transcript levels were calibrated against
standard curves generated from cloned PCR products, and then standardized to the sample
levels of β-actin, as described under “Experimental Procedures.” The results are expressed
as the mean ± SEM for RNA samples extracted from eight separate mouse brains. 3-OST-6
expression levels, although low, were significantly above background reactions lacking reverse
transcriptase.
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Fig 2. Neuronal expression of 3-OST-2 and 3-OST-4 in the mouse trigeminal ganglia
In situ hybridizations with 3-OST-2 or 3-OST-4 antisense probes, as indicated, were performed
on trigeminal ganglia longitudinal sections. Hybridization signals are most evident in the dark
field images, seen as white grains. The corresponding hematoxylin/eosin stained bright field
images show sensory ganglion cell bodies (upper portion of images) and an adjacent axon
bundle (lower portion of images). Representative neurons (N), satellite cells (St), and Schwann
cells (Sw) are indicated in these 400X images. For the 3-OST-2 probe, only scattered neurons
exhibited significant hybridization signals (+). The remaining neurons (−) and non-neuronal
cells exhibited a silver grain density that was comparable to control hybridizations with a sense
probe (non shown). The 3-OST-4 signal is especially conspicuous over the majority of neuronal
cell bodies. Reduced yet significant signal is also evident over satellite cells adjacent to highly
expressive neurons (*). Silver grain density over axons was comparable to the background of
the 3-OST-4 control sense probe (not shown)
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Fig 3. 3-OST-2 and 3-OST-4 are the predominant 3-OST isoforms expressed by sensory neurons
of the trigeminal ganglion
Individual sensory neurons with satellite cells (Neuronal cell bodies) or axonal processes with
Schwann cells (Axons) were isolated from 8 μm cryosections of mouse trigeminal ganglia by
LCM (Cap). Total RNA was extracted from samples containing approximately 100 neurons
or 400 Schwann cells, then linearly-amplified RNA was subjected to real-time RT-PCR, as
described under “Experimental Procedures”. (A) Hematoxylin and eosin stained sections
(200X) before and after LCM, as indicated. For the neuronal samples, contaminating satellite
cells comprised about 10% of the sample volume. (B) Expression of 3-OST isoforms in the
indicated samples are the mean ± range from two independent cell isolations. Results are
standardized to levels of β-actin.
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Fig 4. Composite cDNA nucleotide and predicted amino acid sequences of human 3-OST-4
The cDNA sequence was compiled from overlapping genomic and cDNA sequences. Shown
within the nucleic acid sequence are the polyadenylation signal (single underline) and a pure
GC inverted repeat (double underline). Shown within the amino acid sequence are the
transmembrane domain (boxed), the start of the sulfotransferase domain (arrow), and predicted
sites for O-linked (*) and N-linked (dot underlined) glycosylation. Protein structural features
were detected as previously described (Shworak et al., 1999). This sequence is GenBank
accession number AF105378.
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Fig 5. Identification of 3-OST-2/4-type products
HS, extracted from CHO[Eco] cells transduced with empty retroviral vector (Mock) or vectors
expressing the indicated enzymes, was digested with Hep I-III and the derived residues were
subjected to LC/MS analysis, as described under “Experimental Procedures”. Enzymatic
cleavage converts GlcA/IdoA to ΔUA. For simplicity, the data are presented as the extracted
ion current for sulfated HS saccharide residues only. Residues common to all chromatograms
are indicated in the top (Mock) panel. 3-O-sulfated residues resulting from retroviral
transduction are indicated in the 3-OST-2 and 3-OST-4 panels. Retention times varied slightly
between duplicate runs of the same sample, so peak assignments were confirmed by their mass
spectrographs (not shown), as we have previously described (Lawrence et al., 2004). Shown
to the right are enlargements of the 62 – 70 min region with separate tracings indicating
compounds having m/z values (± 0.2 atomic mass units) consistent with sulfated
tetrasaccharide residues (solid line) or the fully sulfated disaccharide, ΔUA2S→GlcNS3S6S
(broken line). The open arrow indicates apparent contaminating species having m/z values
inconsistent with but within the tolerance set for HS saccharide residues.
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Fig 6. 3-OST-2/4-type HS products occur in select neural tissues
LC/MS analysis of Hep I-III digested HS extracted from the indicated mouse tissues. For
simplicity we present data for two diagnostic molecular ions. The chromatograms show the
extracted ion current for compounds having m/z values (± 0.2 atomic mass units) consistent
with ΔUA2S→GlcNS3S6S and Tetra B. Beneath are mass spectra for the [M-2H+DBA]-1
form of ΔUA2S→GlcNS3S6S and the [M-2H]-2 form of Tetra B. For the Tetra-B [M-2H]-2
molecular ion (m/z of 536 atomic mass units), the -2 charge is confirmed by the isotopic cluster,
which shows 0.5 atomic mass unit difference between adjacent peaks. For the
ΔUA2S→GlcNS3S6S [M-2H+DBA]-1 molecular ion (m/z of 785 atomic mass units), the
isotopic cluster progresses by 1 atomic mass unit, indicating the charge of -1. The trigeminal
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sample also contains a contaminant (masses indicated in italics) co-eluting within the
ΔUA2S→GlcNS3S6S region, which is distinguished by its m/z of 786.6 atomic mass units
and its charge of -2 (peaks differing by 0.5 atomic mass units). The 787.1 peak likely contains
signal from both the 3-O-sulfated disaccharide and the contaminant. For the cerebellum, the
mass spectra corresponding to the elution ranges seen in both the trigeminal and the brain stem
verified the absence of these species in cerebellar HS.
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Fig 7. 3-OST-2 and 3-OST-4 expression converts resistant CHO cells to susceptibility to HSV-1
entry
CHO cells were transfected with plasmids expressing the indicated 3-OST constructs or the
empty vector (pcDNA3.1). Transfectants were exposed to serial dilutions of HSV-1(KOS)tk12,
which expresses β-galactosidase from an insert in the viral genome. Viral entry-dependent β-
galactosidase activity was quantitated at 6 h after the addition of virus, as described under
“Experimental Procedures”. Representative values from a single transfection show the
amount of reaction product detected spectrophotometrically (A405) as the mean from 3 wells
per virus dose. Standard deviations were typically <15% of the mean. Comparable results were
obtained in 5 independent transfection experiments.
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Fig 8. The 3-OST multigene family is comprised of two structurally and functionally defined groups
The dendrogram of the human 3-OST multigene family shows the degree of sequence
homology (% Similarity) within the previously defined sulfotransferase domain (Shworak et
al., 1999;Yabe et al., 2001). Indicated are the preferred HS motifs generated by each enzyme,
gD- or antithrombin (AT)-binding sites, (Shukla et al., 1999;Shworak et al., 1996;Shworak et
al., 1997;Xia et al., 2002;Xu et al., 2005, and data herein), and the resulting structural/functional
categories. The dendrogram was generated with the University of Wisconsin Genetics
Computer Group program “Distances” using amino acid sequences from GenBank/EMBL/
DDBJ accession numbers: AF019386 (3-OST-1), AF105374 (3-OST-2), AF105376 (3-
OST-3A), AF105377 (3-OST-3B), AF105378 (3-OST-4), AF50392 (3-OST-5), and
AY574375 (3-OST-6).
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